Company registration number SC657022 (Scotland)
XIAS BIO LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
XIAS BIO LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
XIAS BIO LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
40,205
-
0
Tangible assets
4
667,433
159,207
707,638
159,207
Current assets
Stocks
15,000
11,167
Debtors
5
127,182
45,354
Cash at bank and in hand
1,822,872
3,187,194
1,965,054
3,243,715
Creditors: amounts falling due within one year
6
(91,038)
(68,482)
Net current assets
1,874,016
3,175,233
Total assets less current liabilities
2,581,654
3,334,440
Creditors: amounts falling due after more than one year
7
-
0
(16,185)
Net assets
2,581,654
3,318,255
Capital and reserves
Called up share capital
74,646
74,646
Share premium account
3,785,901
3,785,901
Profit and loss reserves
(1,278,893)
(542,292)
Total equity
2,581,654
3,318,255
XIAS BIO LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 SEPTEMBER 2025
30 September 2025
- 2 -

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 19 August 2026 and are signed on its behalf by:
A F Fawzy
Director
Company registration number SC657022 (Scotland)
XIAS BIO LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 3 -
1
Accounting policies
Company information

Xias Bio Limited is a private company, limited by shares, registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.

1.2
Revenue

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

1.3
Intangible fixed assets other than goodwill
Software
20% ona straight line basis
1.4
Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Leasehold improvements
10% on a straight line basis
Plant and equipment
25% on a reducing balance basis
Fixtures and fittings
25% on a reducing balance basis
Computers
33% on a straight line basis
1.5
Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

1.6
Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

 

Current or deferred taxation assets and liabilities are not discounted.

 

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Current tax
XIAS BIO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

 

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

 

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

1.7
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
11
6
3
Intangible fixed assets
Other
£
Cost
At 1 October 2024
-
0
Additions
43,860
At 30 September 2025
43,860
Amortisation and impairment
At 1 October 2024
-
0
Amortisation charged for the year
3,655
At 30 September 2025
3,655
Carrying amount
At 30 September 2025
40,205
At 30 September 2024
-
0
XIAS BIO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 October 2024
-
0
180,802
180,802
Additions
365,899
235,286
601,185
At 30 September 2025
365,899
416,088
781,987
Depreciation and impairment
At 1 October 2024
-
0
21,595
21,595
Depreciation charged in the year
18,295
74,664
92,959
At 30 September 2025
18,295
96,259
114,554
Carrying amount
At 30 September 2025
347,604
319,829
667,433
At 30 September 2024
-
0
159,207
159,207
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
7,139
6,398
Other debtors
120,043
38,956
127,182
45,354
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
44,630
19,109
Taxation and social security
16,149
4,045
Other creditors
30,259
45,328
91,038
68,482
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
-
0
16,185
2025-09-302024-10-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.200No description of principal activityD J HarveyA F FawzyS ChambersE NgSC6570222024-10-012025-09-30SC6570222025-09-30SC6570222024-09-30SC657022core:IntangibleAssetsOtherThanGoodwill2025-09-30SC657022core:IntangibleAssetsOtherThanGoodwill2024-09-30SC657022core:LandBuildings2025-09-30SC657022core:OtherPropertyPlantEquipment2025-09-30SC657022core:LandBuildings2024-09-30SC657022core:OtherPropertyPlantEquipment2024-09-30SC657022core:WithinOneYear2025-09-30SC657022core:WithinOneYear2024-09-30SC657022core:CurrentFinancialInstrumentscore:WithinOneYear2025-09-30SC657022core:CurrentFinancialInstrumentscore:WithinOneYear2024-09-30SC657022core:Non-currentFinancialInstrumentscore:AfterOneYear2025-09-30SC657022core:Non-currentFinancialInstrumentscore:AfterOneYear2024-09-30SC657022core:ShareCapital2025-09-30SC657022core:ShareCapital2024-09-30SC657022core:SharePremium2025-09-30SC657022core:SharePremium2024-09-30SC657022core:RetainedEarningsAccumulatedLosses2025-09-30SC657022core:RetainedEarningsAccumulatedLosses2024-09-30SC657022bus:Director22024-10-012025-09-30SC657022core:ComputerSoftware2024-10-012025-09-30SC657022core:LeaseholdImprovements2024-10-012025-09-30SC657022core:PlantMachinery2024-10-012025-09-30SC657022core:FurnitureFittings2024-10-012025-09-30SC657022core:ComputerEquipment2024-10-012025-09-30SC6570222023-10-012024-09-30SC657022core:IntangibleAssetsOtherThanGoodwill2024-09-30SC657022core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-30SC657022core:LandBuildings2024-09-30SC657022core:OtherPropertyPlantEquipment2024-09-30SC6570222024-09-30SC657022core:LandBuildings2024-10-012025-09-30SC657022core:OtherPropertyPlantEquipment2024-10-012025-09-30SC657022core:CurrentFinancialInstruments2025-09-30SC657022core:CurrentFinancialInstruments2024-09-30SC657022core:Non-currentFinancialInstruments2025-09-30SC657022core:Non-currentFinancialInstruments2024-09-30SC657022bus:PrivateLimitedCompanyLtd2024-10-012025-09-30SC657022bus:SmallCompaniesRegimeForAccounts2024-10-012025-09-30SC657022bus:FRS1022024-10-012025-09-30SC657022bus:AuditExempt-NoAccountantsReport2024-10-012025-09-30SC657022bus:Director12024-10-012025-09-30SC657022bus:Director32024-10-012025-09-30SC657022bus:Director42024-10-012025-09-30SC657022bus:FullAccounts2024-10-012025-09-30xbrli:purexbrli:sharesiso4217:GBP